Heavican-Foral TB, Korell F, Scarfo I, Wiggers CRM, et al. Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma. Leukemia 2025 Jul 30. doi: 10.1038/s41375-025-02697.
PMID: 40739330